β2-Adrenergic receptor agonists: a new treatment for diabetic kidney disease?

Zhiwen Liu; Zheng Dong

doi:10.1152/ajprenal.00299.2023

β2-Adrenergic receptor agonists: a new treatment for diabetic kidney disease?

Cellular Biology and Anatomy

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	F1-F2
Journal	American Journal of Physiology - Renal Physiology
Volume	326
Issue number	1
DOIs	https://doi.org/10.1152/ajprenal.00299.2023
State	Published - Jan 2024

ASJC Scopus subject areas

Physiology
Urology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1152/ajprenal.00299.2023

Cite this

@article{4a40f44852fd44468c802507fb515bbb,

title = "β2-Adrenergic receptor agonists: a new treatment for diabetic kidney disease?",

author = "Zhiwen Liu and Zheng Dong",

year = "2024",

month = jan,

doi = "10.1152/ajprenal.00299.2023",

language = "English (US)",

volume = "326",

pages = "F1--F2",

journal = "American Journal of Physiology - Renal Physiology",

issn = "1931-857X",

publisher = "American Physiological Society",

number = "1",

}

TY - JOUR

T1 - β2-Adrenergic receptor agonists

T2 - a new treatment for diabetic kidney disease?

AU - Liu, Zhiwen

AU - Dong, Zheng

PY - 2024/1

Y1 - 2024/1

UR - http://www.scopus.com/inward/record.url?scp=85181239264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85181239264&partnerID=8YFLogxK

U2 - 10.1152/ajprenal.00299.2023

DO - 10.1152/ajprenal.00299.2023

M3 - Editorial

C2 - 37916283

AN - SCOPUS:85181239264

SN - 1931-857X

VL - 326

SP - F1-F2

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

IS - 1

ER -

β2-Adrenergic receptor agonists: a new treatment for diabetic kidney disease?

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this